Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-23-000050
Filing Date
2023-08-08
Accepted
2023-08-08 16:29:33
Documents
88
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20230630.htm   iXBRL 10-Q 1282517
2 EX-31.1 supn-20230630x10qxex311.htm EX-31.1 9655
3 EX-31.2 supn-20230630x10qxex312.htm EX-31.2 10016
4 EX-32.1 supn-20230630x10qxex321.htm EX-32.1 4896
5 EX-32.2 supn-20230630x10qxex322.htm EX-32.2 4917
  Complete submission text file 0001356576-23-000050.txt   7590504

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20230630.xsd EX-101.SCH 46466
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20230630_cal.xml EX-101.CAL 84498
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20230630_def.xml EX-101.DEF 269407
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20230630_lab.xml EX-101.LAB 704826
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20230630_pre.xml EX-101.PRE 475117
82 EXTRACTED XBRL INSTANCE DOCUMENT supn-20230630_htm.xml XML 1127734
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 231151853
SIC: 2834 Pharmaceutical Preparations